Dr. Eric Verdin is the President and CEO of the Buck Institute for Research on Aging – a pioneering biomedical research institute dedicated to aging and age-related disease. A native of Belgium, Dr. Verdin received his Doctorate of Medicine from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health, the Picower Institute for Medical Research, the Gladstone Institutes and UCSF.

Dr. Verdin is currently a professor of medicine at the University of California, San Francisco and the University of Southern California. In 2016 Dr. Verdin established his laboratory at the Buck Institute for Research on Aging to study the relationship between aging, metabolism and the immune system. He is an elected member of several scientific organizations, including several National Academies, the American Association for the Advancement of Science, the American Society for Clinical Investigation and the Association of American Physicians. He has published close to 300 papers, is highly cited (top 1% of all scientists), holds 17 patents and is the founder for 4 different biotech companies.